Takashi Semba, Ryo Sato, Akiyoshi Kasuga, Kentaro Suina, Tatsuhiro Shibata, Takashi Kohno, Makoto Suzuki, Hideyuki Saya, Yoshimi Arima. Lung Adenocarcinoma Mouse Models Based on Orthotopic Transplantation of Syngeneic Tumor-Initiating Cells Expressing EpCAM, SCA-1, and Ly6d. Cancers (Basel). 2020.12; 12 (12): ( PubMed, DOI )

Mari Hosonaga, Hideyuki Saya, Yoshimi Arima. Molecular and cellular mechanisms underlying brain metastasis of breast cancer. Cancer Metastasis Rev. 2020.09; 39 (3): 711-720. ( PubMed, DOI )

Yoshimi Arima, Hiroyuki Nobusue, Hideyuki Saya. Targeting of cancer stem cells by differentiation therapy. Cancer Sci. 2020.08; 111 (8): 2689-2695. ( PubMed, DOI )

Mari Hosonaga, Yoshimi Arima, Oltea Sampetrean, Daisuke Komura, Ikuko Koya, Takashi Sasaki, Eiichi Sato, Hideyuki Okano, Jun Kudoh, Shumpei Ishikawa, Hideyuki Saya, Takashi Ishikawa. HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer. Int J Mol Sci. 2018.07; 19 (8): ( PubMed, DOI )

T Ouchi, S Morikawa, S Shibata, M Takahashi, M Yoshikawa, T Soma, H Miyashita, W Muraoka, K Kameyama, H Kawana, Y Arima, H Saya, H Okano, T Nakagawa, S Asoda. Recurrent Spindle Cell Carcinoma Shows Features of Mesenchymal Stem Cells. J Dent Res. 2018.07; 97 (7): 779-786. ( PubMed, DOI )

Takashi Semba, Eiji Sugihara, Nagisa Kamoshita, Sayaka Ueno, Keitaro Fukuda, Masafumi Yoshino, Kazumasa Takao, Kazunori Yoshikawa, Kenji Izuhara, Yoshimi Arima, Makoto Suzuki, Hideyuki Saya. Periostin antisense oligonucleotide suppresses bleomycin-induced formation of a lung premetastatic niche for melanoma. Cancer Sci. 2018.05; 109 (5): 1447-1454. ( PubMed, DOI )

Ritsuko Harigai, Shigeki Sakai, Hiroyuki Nobusue, Chikako Hirose, Oltea Sampetrean, Noriaki Minami, Yukie Hata, Takashi Kasama, Takanori Hirose, Toshiki Takenouchi, Kenjiro Kosaki, Kazuo Kishi, Hideyuki Saya, Yoshimi Arima. Tranilast inhibits the expression of genes related to epithelial-mesenchymal transition and angiogenesis in neurofibromin-deficient cells. Sci Rep. 2018.04; 8 (1): 6069. ( PubMed, DOI )

Yuji Otsuki, Hideyuki Saya, Yoshimi Arima. Prospects for new lung cancer treatments that target EMT signaling. Dev Dyn. 2018.03; 247 (3): 462-472. ( PubMed, DOI )

Noriaki Minami, Yusuke Maeda, Shunsuke Shibao, Yoshimi Arima, Fumiharu Ohka, Yutaka Kondo, Koji Maruyama, Masatoshi Kusuhara, Takashi Sasayama, Eiji Kohmura, Hideyuki Saya, Oltea Sampetrean. Organotypic brain explant culture as a drug evaluation system for malignant brain tumors. Cancer Med. 2017.11; 6 (11): 2635-2645. ( PubMed, DOI )

Takashi Semba, Yoshimi Arima. Epithelial-mesenchymal transition is predetermined by the epigenetic state of the skin tumor cell of origin. Stem Cell Investig. 2017; 4 37. ( PubMed, DOI )

Ryo Sato, Teppei Nakano, Mari Hosonaga, Oltea Sampetrean, Ritsuko Harigai, Takashi Sasaki, Ikuko Koya, Hideyuki Okano, Jun Kudoh, Hideyuki Saya, Yoshimi Arima. RNA Sequencing Analysis Reveals Interactions between Breast Cancer or Melanoma Cells and the Tissue Microenvironment during Brain Metastasis. Biomed Res Int. 2017; 2017 8032910. ( PubMed, DOI )

Yayoi Takamoto, Yoshimi Arima, Hideyuki Saya. Development of mouse models of malignant phyllodes tumors by transplantation of syngeneic mammary gland cells expressing mutant H-Ras. Genes Cells. 2016.11; 21 (11): 1244-1252. ( PubMed, DOI )

Ryo Sato, Takashi Semba, Hideyuki Saya, Yoshimi Arima. Concise Review: Stem Cells and Epithelial-Mesenchymal Transition in Cancer: Biological Implications and Therapeutic Targets. Stem Cells. 2016.08; 34 (8): 1997-2007. ( PubMed, DOI )

Kazuhiro Umeyama, Kota Watanabe, Masahito Watanabe, Keisuke Horiuchi, Kazuaki Nakano, Masateru Kitashiro, Hitomi Matsunari, Tokuhiro Kimura, Yoshimi Arima, Oltea Sampetrean, Masaki Nagaya, Masahiro Saito, Hideyuki Saya, Kenjiro Kosaki, Hiroshi Nagashima, Morio Matsumoto. Generation of heterozygous fibrillin-1 mutant cloned pigs from genome-edited foetal fibroblasts. Sci Rep. 2016.04; 6 24413. ( PubMed, DOI )

Ryo Maruoka, Toshiki Takenouchi, Chiharu Torii, Atsushi Shimizu, Kumiko Misu, Koichiro Higasa, Fumihiko Matsuda, Arihito Ota, Katsumi Tanito, Akira Kuramochi, Yoshimi Arima, Fujio Otsuka, Yuichi Yoshida, Keiji Moriyama, Michihito Niimura, Hideyuki Saya, Kenjiro Kosaki. The use of next-generation sequencing in molecular diagnosis of neurofibromatosis type 1: a validation study. Genet Test Mol Biomarkers. 2014.11; 18 (11): 722-735. ( PubMed, DOI )

Mari Hosonaga, Yoshimi Arima, Eiji Sugihara, Norio Kohno, Hideyuki Saya. Expression of CD24 is associated with HER2 expression and supports HER2-Akt signaling in HER2-positive breast cancer cells. Cancer Sci. 2014.07; 105 (7): 779-787. ( PubMed, DOI )

K Kai, T Iwamoto, T Kobayashi, Y Arima, Y Takamoto, N Ohnishi, C Bartholomeusz, R Horii, F Akiyama, G N Hortobagyi, L Pusztai, H Saya, N T Ueno. Ink4a/Arf(-/-) and HRAS(G12V) transform mouse mammary cells into triple-negative breast cancer containing tumorigenic CD49f(-) quiescent cells. Oncogene. 2014.01; 33 (4): 440-448. ( PubMed, DOI )

Takaaki M Goto, Yoshimi Arima, Osamu Nagano, Hideyuki Saya. Lysyl oxidase is induced by cell density-mediated cell cycle suppression via RB-E2F1-HIF-1α axis. Cell Struct Funct. 2013; 38 (1): 9-14. ( PubMed, DOI )

Yoshimi Arima, Naoki Hayashi, Hidemi Hayashi, Mikako Sasaki, Kazuharu Kai, Eiji Sugihara, Eriko Abe, Atsushi Yoshida, Shuji Mikami, Seigo Nakamura, Hideyuki Saya. Loss of p16 expression is associated with the stem cell characteristics of surface markers and therapeutic resistance in estrogen receptor-negative breast cancer. Int J Cancer. 2012.06; 130 (11): 2568-2579. ( PubMed, DOI )

Tatsuyuki Chiyoda, Naoyuki Sugiyama, Takatsune Shimizu, Hideaki Naoe, Yusuke Kobayashi, Jo Ishizawa, Yoshimi Arima, Hiroshi Tsuda, Masaaki Ito, Kozo Kaibuchi, Daisuke Aoki, Yasushi Ishihama, Hideyuki Saya, Shinji Kuninaka. LATS1/WARTS phosphorylates MYPT1 to counteract PLK1 and regulate mammalian mitotic progression. J Cell Biol. 2012.05; 197 (5): 625-641. ( PubMed, DOI )

Yoshimi Arima, Hidemi Hayashi, Mikako Sasaki, Mari Hosonaga, Takaaki M Goto, Tatsuyuki Chiyoda, Shinji Kuninaka, Tatsuhiro Shibata, Hirokazu Ohata, Hitoshi Nakagama, Yoichi Taya, Hideyuki Saya. Induction of ZEB proteins by inactivation of RB protein is key determinant of mesenchymal phenotype of breast cancer. J Biol Chem. 2012.03; 287 (11): 7896-7906. ( PubMed, DOI )

Yoshimi Arima, Hidemi Hayashi, Kanako Kamata, Takaaki M Goto, Mikako Sasaki, Akira Kuramochi, Hideyuki Saya. Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1. Exp Dermatol. 2010.08; 19 (8): e136-e141. ( PubMed, DOI )

Kazuharu Kai, Yoshimi Arima, Toshio Kamiya, Hideyuki Saya. Breast cancer stem cells. Breast Cancer. 2010.04; 17 (2): 80-85. ( PubMed, DOI )

Kazuharu Kai, Osamu Nagano, Eiji Sugihara, Yoshimi Arima, Oltea Sampetrean, Takatsugu Ishimoto, Masaya Nakanishi, Naoto T Ueno, Hirotaka Iwase, Hideyuki Saya. Maintenance of HCT116 colon cancer cell line conforms to a stochastic model but not a cancer stem cell model. Cancer Sci. 2009.12; 100 (12): 2275-2282. ( PubMed, DOI )

Yoshimi Arima, Yasumichi Inoue, Tatsuhiro Shibata, Hidemi Hayashi, Osamu Nagano, Hideyuki Saya, Yoichi Taya. Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition. Cancer Res. 2008.07; 68 (13): 5104-5112. ( PubMed, DOI )

Christian Bronner, Mayada Achour, Yoshimi Arima, Thierry Chataigneau, Hideyuki Saya, Valérie B Schini-Kerth. The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future? Pharmacol Ther. 2007.09; 115 (3): 419-434. ( PubMed, DOI )

S Kuninaka, S-I Iida, T Hara, M Nomura, H Naoe, T Morisaki, M Nitta, Y Arima, T Mimori, S Yonehara, H Saya. Serine protease Omi/HtrA2 targets WARTS kinase to control cell proliferation. Oncogene. 2007.04; 26 (17): 2395-2406. ( PubMed, DOI )

Yoshihiro Komohara, Mamoru Harada, Yoshimi Arima, Shigetaka Suekane, Masanori Noguchi, Akira Yamada, Kyogo Itoh, Kei Matsuoka. Identification of target antigens in specific immunotherapy for renal cell carcinoma. J Urol. 2007.03; 177 (3): 1157-1162. ( PubMed, DOI )

Yoshihiro Komohara, Mamoru Harada, Yoshimi Arima, Shigetaka Suekane, Masanori Noguchi, Akira Yamada, Kyogo Itoh, Kei Matsuoka. Anti-cancer vaccine candidates in specific immunotherapy for bladder carcinoma. Int J Oncol. 2006.12; 29 (6): 1555-1560. ( PubMed )

Yoshimi Arima, Satoko Matsueda, Hirohisa Yano, Mamoru Harada, Kyogo Itoh. Parathyroid hormone-related protein as a common target molecule in specific immunotherapy for a wide variety of tumor types. Int J Oncol. 2005.10; 27 (4): 981-988. ( PubMed )

Naoki Yajima, Ryuya Yamanaka, Takashi Mine, Naoto Tsuchiya, Jumpei Homma, Masakazu Sano, Terukazu Kuramoto, Yayoi Obata, Nobukazu Komatsu, Yoshimi Arima, Akira Yamada, Minoru Shigemori, Kyogo Itoh, Ryuichi Tanaka. Immunologic evaluation of personalized peptide vaccination for patients with advanced malignant glioma. Clin Cancer Res. 2005.08; 11 (16): 5900-5911. ( PubMed, DOI )

Shinji Kuninaka, Masanobu Nomura, Toru Hirota, Shin-Ichi Iida, Toshihiro Hara, Shinobu Honda, Naoko Kunitoku, Takashi Sasayama, Yoshimi Arima, Tomotoshi Marumoto, Kageharu Koja, Shin Yonehara, Hideyuki Saya. The tumor suppressor WARTS activates the Omi / HtrA2-dependent pathway of cell death. Oncogene. 2005.08; 24 (34): 5287-5298. ( PubMed, DOI )

Yoshimi Arima, Masayuki Nitta, Shinji Kuninaka, Dongwei Zhang, Toshiyoshi Fujiwara, Yoichi Taya, Mitsuyoshi Nakao, Hideyuki Saya. Transcriptional blockade induces p53-dependent apoptosis associated with translocation of p53 to mitochondria. J Biol Chem. 2005.05; 280 (19): 19166-19176. ( PubMed, DOI )

Yi Wang, Mamoru Harada, Hirohisa Yano, Sachiko Ogasawara, Hiroko Takedatsu, Yoshimi Arima, Satoko Matsueda, Akira Yamada, Kyogo Itoh. Prostatic acid phosphatase as a target molecule in specific immunotherapy for patients with nonprostate adenocarcinoma. J Immunother. 2005; 28 (6): 535-541. ( PubMed, DOI )

Dongwei Zhang, Toru Hirota, Tomotoshi Marumoto, Michio Shimizu, Naoko Kunitoku, Takashi Sasayama, Yoshimi Arima, Liping Feng, Misao Suzuki, Motohiro Takeya, Hideyuki Saya. Cre-loxP-controlled periodic Aurora-A overexpression induces mitotic abnormalities and hyperplasia in mammary glands of mouse models. Oncogene. 2004.11; 23 (54): 8720-8730. ( PubMed, DOI )

Shinobu Honda, Tomotoshi Marumoto, Toru Hirota, Masayuki Nitta, Yoshimi Arima, Michio Ogawa, Hideyuki Saya. Activation of m-calpain is required for chromosome alignment on the metaphase plate during mitosis. J Biol Chem. 2004.03; 279 (11): 10615-10623. ( PubMed, DOI )

Yoshimi Arima, Toru Hirota, Christian Bronner, Marc Mousli, Toshiyoshi Fujiwara, Shin-ichiro Niwa, Hiroyuki Ishikawa, Hideyuki Saya. Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition. Genes Cells. 2004.02; 9 (2): 131-142. ( PubMed, DOI )

Masayuki Nitta, Hiromasa Tsuiki, Yoshimi Arima, Kei Harada, Takahumi Nishizaki, Kousuke Sasaki, Tatsuyuki Mimori, Yukitaka Ushio, Hideyuki Saya. Hyperploidy induced by drugs that inhibit formation of microtubule promotes chromosome instability. Genes Cells. 2002.02; 7 (2): 151-162. ( PubMed, DOI )

酒井 成貴, 有馬 好美, 坂本 好昭, 中島 由佳理, 佐谷 秀行, 貴志 和生. 【神経線維腫症1型(Recklinghausen病)の病態と治療:小児外科医のかかわり・役割】び漫性神経線維腫(diffuse neurofibroma)に対する外科治療 小児外科. 2019.12; 51 (12): 1184-1187. ( 医中誌 )

木村 聖美, 有馬 好美. 【乳癌のすべて】診断・治療の進歩　治療戦略を考えるうえでのLuminal/HER2乳癌の基礎 医学のあゆみ. 2017.04; 261 (5): 463-468. ( 医中誌 )

有馬 好美, 佐藤 亮. 【発がん　遺伝子変異+αの真実に迫る　タール癌から1世紀を超え、いま紐解かれる複雑性】転写因子による上皮間葉転換の制御とがん幹細胞 実験医学. 2016.09;

細永真理, 有馬好美, 佐谷秀行. 乳がん幹細胞～HER2シグナルに関する新たな知見～ 腫瘍内科. 2014.09; 14 (3): 281-287.

有馬 好美, 佐谷 秀行. 【乳癌のバイオロジーと臨床　診断と治療への応用】乳癌におけるRb不活化と上皮間葉転換について 乳癌の臨床. 2011.02;

有馬 好美, 神谷 敏夫, 佐谷 秀行. 【がん転移　臨床と研究の羅針盤】基礎医学編　上皮間葉転換ががんの浸潤転移に果たす役割 細胞工学. 2010.10; 別冊 (がん転移 臨床と研究の羅針盤): 166-169. ( 医中誌 )

有馬 好美, 佐谷 秀行. 神経線維腫形成の分子機構に対する新たな治療戦略の考案 日本レックリングハウゼン病学会雑誌. 2010.10;

有馬 好美, 神谷 敏夫, 佐谷 秀行. 【転移とは何か】基礎　上皮間葉転換と癌浸潤転移 細胞工学. 2009.06; 28 (7): 655-658. ( 医中誌 )

有馬 好美, 佐谷 秀行. 【癌とゲノム】癌におけるゲノム不安定性 ゲノム医学. 2005.04;

春日 章良, 佐谷 秀行, 有馬 好美. 胆道癌ゲノム医療の最前線　オルガノイド技術を用いたヒトがん遺伝子を導入した肝内胆管がん、胆嚢がん、肝外胆管がんのシンジェニックマウスモデルの開発. 胆道 2019.10.01

有馬好美. Approach to identifying the molecular mechanisms of breast cancer brain metastases based on xenograft models. 第78回日本癌学会学術総会 2019.09.01

有馬好美. CDK4/6阻害剤の基礎と臨床. 第７8回日本癌学会学術総会 2019.09.01

Kasuga A., Saya Y., Arima Y.. Biliary tract cancer mouse models based on transplantation of tumor-initiating cells with cancer stem cell properties. 第７8回日本癌学会学術総会 2019.09.01

吉川 桃子, 黄地 健仁, 森川 暁, 芝田 晋介, 高橋 萌, 相馬 智也, 宮下 英高, 村岡 渡, 亀山 香織, 河奈 裕正, 有馬 好美, 佐谷 秀行, 岡野 栄之, 中川 種昭, 莇生田 整治. 口腔に発生した再発紡錘細胞癌における間葉系幹細胞の同定. 頭頸部癌 2019.05.01

有馬好美. Establishment of neurofibroma cells and dedifferentiated fat (DFAT) cells from tumor tissues from patients diagnosed with NF1 (Neurofibromatosis type 1). American Association for Cancer Research Annual Meeting 2019 2019.04.01

有馬好美. NF1患者神経線維腫からの神経線維腫細胞および脱分化脂肪（DFAT）細胞の樹立. 第１０回日本レックリングハウゼン病学会学術大会 2019.02.24

有馬好美. Early diagnostic markers for refractory heterogeneous breast cancers containing squamous-like cancer cells. 11th AACR-JCA Joint Conference on Breakthroughs in Cancer Research 2019.02.01

有馬 好美. Heterogeneous Tumors Composed of Epithelial-type and Mesenchymal-type Breast Cancer Cells. 第７７回日本癌学会学術総会 2018.09.01

Semba T., Sato R., Kasuga A., Suzuki M., Saya H., Arima Y.. Enriching EpCAM+/Sca-1+ mouse bronchioalveolar stem cells to generate lung adenocarcinoma. American Association for Cancer Research Annual Meeting 2018 2018.04.01

Akiyoshi Kasuga, Takashi Semba, Hiromasa Takaishi, Takanori Kanai, Hideyuki Saya, Yoshimi Arima. Intrahepatic cholangiocarcinoma and gallbladder carcinoma mouse model based on transplantation of syngeneic tumor-initiating cells. American Association for Cancer Research Annual Meeting 2018 2018.04.01

有馬好美. The Mutation of the PTPN11 Gene that Encodes SHP-2 Protein Promotes Tumorigenic Activity of the NF1-Deficient cells. American Society for Cell Biology (ASCB) | EMBO Meeting 2017 2017.12.01

Sato R., Semba T., Ichiyasu H., Fujii K., Saya H., Arima Y.. TGF-β Signaling Mediated by Fibroblasts is Associated with the Histological Subtypes of Lung Adenocarcinoma. The IASLC 18th World Conference on Lung Cancer 2017.10.01

有馬 好美. Intratumor Heterogeneity and Cancer Promotion. 第７６回日本癌学会学術総会 2017.09.01

有馬 好美. Intra-tumor Heterogeneity Associated with EMT Contributes to the Progression of Cancer. Gordon Research Conference, Cell Growth & Proliferation 2017.07.01

有馬 好美. Additional Mutation in PTPN11 Gene Promotes Tumorigenesis of the NF1 Gene Mutated Cells. American Association for Cancer Research Annual Meeting 2017 2017.04.01

梅山 一大, 新井 良和, 中野 和明, 内倉 鮎子, 渡邊 將人, 松成 ひとみ, 齋藤 正寛, 木村 徳宏, 渡邉 航太, 堀内 圭輔, 北城 雅照, 有馬 好美, サンペトラ・オルテア , 小崎 健次郎, 佐谷 秀行, 松本 守雄, 長屋 昌樹, 大鐘 潤, 長嶋 比呂志. 変異型fibrillin-1遺伝子を有するブタの上行大動脈の病理解析. 脈管学 2016.10.01

有馬 好美. Tumor Heterogeneity Associated with EMT Contributes to the Progression of Breast Cancer. 第７５回日本癌学会学術総会 2016.10.01

Hosonaga M., Arima Y., Sato E., Yamada K., Kaise H., Kawai Y., Teraoka S., Saya H., Ishikawa T.. Intratumoral Heterogeneity of HER2 Expression is Relevant to Breast Cancer Malignancy. European Society of Clinical Oncology (ESMO) 2016 Congress 2016.10.01

有馬 好美. がん細胞間相互作用とintra-tumor heterogeneity. 第24回日本乳癌学会学術総会 2016.06.01

Takashi Semba, Ryo Sato, Makoto Suzuki, Hideyuki Saya, Yoshimi Arima. EpCAM Positive Lung Cells are Involved in Organoid Formation. American Association for Cancer Research Annual Meeting 2016 2016.04.01

Ryo Sato, Takashi Semba, Hirotsugu Kohrogi, Hideyuki Saya, Yoshimi Arima. The Association between Gastric Mucin 5AC (MUC5AC) Expressions, Transforming Growth Factor-β (TGF-β) Signal, and Histopathological Phenotypes of Lung Cancer in Xenograft Models. American Association for Cancer Research Annual Meeting 2016 2016.04.01

有馬 好美. The Cancer Promoting Mechanism Driven by Intra-tumor Heterogeneity. Tenth AACR-JCA Joint Conference on Breakthroughs in Cancer Research: From Biology to Therapeutics 2016.02.01

有馬 好美. NF1-MPNST 細胞株に対するトラニラストの効果. 第7回日本レックリングハウゼン病学会学術大会 2015.11.29

佐藤 亮, 有馬 好美, 千場 隆, 興梠 博次, 佐谷 秀行. ヒト肺腺癌細胞株A549は移植するマウス組織によって異なる組織型を呈する腫瘍を構築する. 日本癌学会総会記事 2015.10.01

有馬 好美. トリプルネガティブ乳がんにおけるintratumor heterogeneity. 第74回日本癌学会学術総会 2015.10.01

千場 隆, 有馬 好美, 佐藤 亮, 柴田 龍弘, 河野 隆志, 鈴木 実, 佐谷 秀行. Ink4a/Arfノックアウトマウス肺細胞へのKRASG12V、EML4-ALK、EZR-ROS1、KIF5B-RET遺伝子導入によるマウス肺癌モデルの作製. 日本癌学会総会記事 2015.10.01

有馬 好美. トリプルネガティブ乳がんにおけるintra-tumor heterogeneity. 第23回日本乳癌学会 2015.07.01

丸岡 亮, 武内 俊樹, 清水 厚志, 鳥居 千春, 三須 久美子, 日笠 幸一郎, 松田 文彦, 太田 有史, 谷戸 克己, 倉持 朗, 有馬 好美, 大塚 藤男, 吉田 雄一, 森山 啓司, 小崎 里華, 新村 眞人, 佐谷 秀行, 小崎 健次郎. 次世代シークエンサーと解析パネルを用いたNF1遺伝子診断法の構築. 日本レックリングハウゼン病学会雑誌 2015.04.01

有馬 好美. Additional mutations in genes relevant to the Ras signaling pathway promote the malignant characteristics of NF1-associated malignant peripheral nerve sheath tumor (NF1-MPNST) cells. American Association for Cancer Research Annual Meeting 2015 2015.04.01

Takamoto Y., Arima Y., Saya H.. The development of malignant phyllodes tumor models. The 2014 San Antonio Breast Cancer Symposium 2014.12.01

廣瀬 盟子, 有馬 好美, 佐谷 秀行. レックリングハウゼン病に生じる悪性末梢神経鞘腫瘍の異種移植モデル作製. 日本レックリングハウゼン病学会学術大会プログラム・抄録集 2014.10.01

廣瀬 盟子, 有馬 好美, 北川 雄光, 佐谷 秀行. トラニラストはNF1-悪性末梢神経鞘腫瘍細胞の増殖を抑制する(Tranilast Suppresses the Proliferation of NF1-associated Malignant Peripheral Nerve Sheath Tumor (NF1-MPNST) Cells). 日本癌学会総会記事 2014.09.01

Hosonaga M., Arima Y., Saya H.. Effect of HER2 overexpression on cancer stem-like characteristics of triple-negative breast cancer cells. European Society for Medical Oncology (ESMO) 2014 Congress 2014.09.01

有馬 好美. Expression of CD24 Supports HER2-Akt Signaling in HER2-Positive Breast Cancer Cells. 第73回日本癌学会学術総会 2014.09.01

細永 真理, 有馬 好美, 河野 範男, 佐谷 秀行. HER2陽性乳癌におけるCD24発現の意義. 日本乳癌学会総会プログラム抄録集 2014.07.01

有馬 好美. CD24 promotes HER2 signaling pathway and CD24 inhibition sensitizes anti-HER2 therapy in breast cancer. American Association for Cancer Research Annual Meeting 2014 2014.04.01

有馬 好美. 神経線維腫症1型（NF1, レックリングハウゼン病）に生じる神経線維腫モデルの作製. 第36回日本分子生物学会 2013.12.01

有馬 好美. Significance of RB-ZEB axis in EMT phenotype of breast cancer and inhibition of ZEB by CDK4/6 inhibitor. The 2013 San Antonio Breast Cancer Symposium 2013.12.01

細永 真理, 有馬 好美, 河野 範男, 佐谷 秀行. 乳癌のHER2不均一性が脳転移に与える影響. 日本乳癌学会総会プログラム抄録集 2013.06.01

有馬 好美. がん細胞におけるCDK4/6の役割とCDK4/6阻害剤の抗がん剤としての可能性について. 第17回日本がん分子標的治療学会 2013.06.01

有馬 好美. The epithelial-mesenchymal transition-related transcription factor ZEB suppresses Claudin expression in breast cancer cells. American Association for Cancer Research Annual Meeting 2013 2013.04.01

有馬好美. The role of CDK4/6 in cancer cells and the potential therapeutic effects of CDK4/6 inhibitors. 2012 Annual Meeting of the American Society for Cell Biology 2012.12.01

有馬 好美. The role of CDK4/6 in cancer cells and the potential therapeutic effects of CDK4/6 inhibitors. The 17th Japan-Korea Cancer Research Workshop 2012.11.01

千代田 達幸, 國仲 慎治, 増田 健太, 清水 孝恒, 有馬 好美, 津田 浩史, 青木 大輔, 佐谷 秀行. LATS1/MYPT1を介した新規PLK1活性制御機構　分裂期キナーゼの新しい機能連関(LATS1/WARTS phosphorylates MYPT1 to counteract PLK1: Novel link between mitotic kinases). 日本癌学会総会記事 2012.08.01

Hosonaga M., Arima Y., Saya H.. Effect of heterogeneity of HER2 expression on brain metastasis of breast cancer. American Society of Clinical Oncology (ASCO) 2012 Annual Meeting 2012.06.01

有馬 好美. Significance of EMT in breast cancer cells. 第69回日本癌学会 2010.09.01

後藤 孝明, 有馬 好美, 佐谷 秀行. 上皮間葉転換におけるlysyl oxidaseの発現制御機構(Association of lysyl oxidase (LOX) expression with epithelial to mesenchymal transition). 日本癌学会総会記事 2010.08.01

有馬 好美. トリプルネガティブ乳癌におけるRb不活化と上皮間葉転換誘導因子ZEBの発現について. 第18回日本乳癌学会 2010.06.01

有馬 好美. 神経線維腫形成の分子機構. 第1回日本レックリングハウゼン病学会学術大会 2009.11.01

有馬 好美. 癌におけるRb不活化に基づく上皮間葉転換（EMT）誘導. 第82回日本生化学会大会 2009.10.01

古谷 正敬, 浅田 弘法, 升田 博隆, 内田 浩, 鎌田 可奈子, 有馬 好美, 後藤 孝明, 今井 樹, 丹羽 眞一郎, 本田 律生, 片渕 秀隆, 吉村 泰典, 佐谷 秀行. 子宮内膜症病巣腺上皮細胞におけるEMT関連マーカーの免疫組織化学的検討. 日本生殖医学会雑誌 2009.10.01

浅田 弘法, 古谷 正敬, 升田 博隆, 鎌田 可奈子, 有馬 好美, 後藤 孝明, 今井 樹, 丹羽 眞一郎, 本田 律生, 片渕 秀隆, 吉村 泰典, 佐谷 秀行. 子宮内膜腺上皮細胞におけるEMT関連マーカーの免疫組織化学的検討. 日本生殖医学会雑誌 2009.10.01

有馬 好美. Significance of Rb pathway in the epithelial to mesenchymal transition inducing cancer invasion and metastasis. The 9th Korea-Japan Symposium on Cancer and Ageing Research 2009.03.01

有馬 好美. Significance of Rb pathway in the epithelial to mesenchymal transition inducing cancer invasion and metastasis. 第67回日本癌学会 2008.10.01

林 秀美, 有馬 好美, 丹羽 眞一郎, 佐谷 秀行. 乳がん悪性化におけるRbとZeb1の役割(Roles of Rb and Zeb1 in breast cancer malignancy). 日本癌学会総会記事 2008.09.01

有馬 好美. Rb depletion induces cellular phenotypic changes characteristic of epithelial to mesenchymal transition (EMT). 第66回日本癌学会 2007.10.01

有馬 好美. Analysis of novel p53-dependent cell death mechanism. 第64回日本癌学会 2005.09.01

松枝 智子, 有馬 好美, 矢野 博久, 原田 守, 伊東 恭悟. PTH-rPは種々の上皮性癌に対する特異的免疫療法の有用な標的分子である. 日本癌学会総会記事 2005.09.01

有馬 好美. p53-dependent apoptosis induced by transcriptional blockage. 第63回日本癌学会 2004.12.01

有馬 好美. p53-dependent apoptosis induced by transcriptional blockage. 第27回日本分子生物学会 2004.09.01

本田 志延, 丸本 朋稔, 有馬 好美, 広田 亨, 小川 道雄, 佐谷 秀行. カルパイン阻害剤による分裂期停止機構. 日本癌学会総会記事 2002.10.01

広田 亨, 森崎 哲朗, 有馬 好美, 飯田 伸一, 原 敏浩, 丸本 朋稔, 国徳 尚子, 國仲 慎治, 畠山 勝義, 佐谷 秀行. warts kinaseによるG2/M制御機構の解析. 日本癌学会総会記事 2000.09.01

有馬 好美. ヒトCD4+ T細胞におけるglycolipidsのHIV増殖促進作用. 日本細菌学雑誌 1998.02.01